0
Skip to Content
RApport
🔍 Search
Stories
All Stories
All Biotech
All Planetary Health
Culture
Finance
Policy
Science
About
Resources
Disclosure
SUBSCRIBE
RApport
🔍 Search
Stories
All Stories
All Biotech
All Planetary Health
Culture
Finance
Policy
Science
About
Resources
Disclosure
SUBSCRIBE
🔍 Search
Folder: Stories
Back
All Stories
All Biotech
All Planetary Health
Culture
Finance
Policy
Science
About
Resources
Disclosure
SUBSCRIBE

Science

Policy

Culture

Finance

RA TV: How do we determine what a drug is worth?
Policy, Biotech Chris Morrison 11/4/21 Policy, Biotech Chris Morrison 11/4/21

RA TV: How do we determine what a drug is worth?

In this month’s episode, we discuss the latest COVID news. Then Peter Kolchinsky talks with our guest, Dr. Joshua Cohen of Tufts Medical Center, about how they estimate the value of a drug.

Read More
RA TV: Past, present, & future
Science, Biotech Thomas Culman 9/13/21 Science, Biotech Thomas Culman 9/13/21

RA TV: Past, present, & future

In this month’s episode of RA TV, we look back at the past year for biotech, examine today’s headlines, and contemplate the future of this pandemic — and maybe the next one.

Read More
RA TV: Aduhelm &amp; Patient-Centered Healthcare Reforms</a>
Policy, Science, Biotech Guest User 8/26/21 Policy, Science, Biotech Guest User 8/26/21

RA TV: Aduhelm & Patient-Centered Healthcare Reforms

Listen in as RA Capital’s TechAtlas Associates convene to discuss recent Covid-19 news. Learn about the emerging Delta variant, new data from Novavax and CureVac, and the potential association between mRNA vaccines and myocarditis.

Read More
RA TV: Vaccines versus variants
Science, Biotech Guest User 7/8/21 Science, Biotech Guest User 7/8/21

RA TV: Vaccines versus variants

Listen in as RA Capital’s TechAtlas Associates convene to discuss recent Covid-19 news. Learn about the emerging Delta variant, new data from Novavax and CureVac, and the potential association between mRNA vaccines and myocarditis.

Read More
RAPPORT_PRIMARY_LOGO_Full_72.png

Home

Stories

About

Contact

Disclosure

© Copyright 2001-2025 RA Capital Management, L.P. This website is for informational purposes only and does not constitute an offer to provide investment advisory or other services by RA Capital Management, L.P. (“RA Capital”). Nothing contained on the website constitutes investment advice, and the views expressed should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company. In preparing the information contained in this website, RA Capital has not taken into account the investment needs, objectives, and financial circumstances of any particular investor, and investments and companies referenced may not be suitable for all investors. Any views expressed were prepared based upon information available and believed to be reliable at the time such views were written. RA Capital makes no guarantees as to their accuracy or completeness. All information is subject to change and may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. By accessing this website, you agree not to copy, reproduce, republish, upload, post, transmit, alter, or distribute, in any way, content or materials from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of RA Capital.
Tweets by rapport_bio